Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12614000749606Phase 4Completed
Phase 4, open-label trial of bupivacaine (2 arms), sponsored by Dr. Mehmet AKSOY. Primary endpoints: Mean arterial blood pressure, Heart rate and 1 more. Started Jan 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12614000749606.